Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (69)

2024

  1. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

2023

  1. Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke

    Neurologia, Vol. 38, Núm. 3, pp. 150-158

  2. Characteristics of stroke units and stroke teams in Spain in 2018. Pre2Ictus project

    Neurologia, Vol. 38, Núm. 3, pp. 173-180

  3. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories

    REC: CardioClinics, Vol. 58, Núm. 2, pp. 119-128

  4. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Cirugia Cardiovascular, Vol. 30, Núm. 3, pp. 174-181

  5. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Revista Clinica Espanola

  6. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 501-510

  7. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Nefrologia, Vol. 43, Núm. 4, pp. 474-483

  8. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?

    Revista clinica espanola, Vol. 223, Núm. 7, pp. 440-449

  9. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?

    Advances in Laboratory Medicine, Vol. 4, Núm. 2, pp. 147-156

  10. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  11. Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia: revisión de la evidencia actual

    Revista de neurologia, Vol. 76, Núm. 1, pp. 21-30

  12. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

  3. Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Circulating extracellular vesicle proteins and microRNA profiles in subcortical and cortical-subcortical ischaemic stroke

    Biomedicines, Vol. 9, Núm. 7

  3. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  4. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

    Journal of Headache and Pain, Vol. 22, Núm. 1